![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Centaur Pharmaceuticals Private Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Temazepam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number CEP 2010-282 - Rev 02
This Chemical Type CEP, issued on October 19, 2023, remains in force until May 31, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 954 associated with this CEP further emphasizes